Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Population-based eGFR charts may be beneficial for early identification and prevention of chronic kidney disease.
By: Jon CostelloGreenfire Resources (GFR) (GFR:CA) is in the bull’s eye of what today’s market dislikes. It’s a microcap Canadian oil-sands producer that has been beset by management upheaval and ...
Adults with prediabetes were more than twice as likely as those with normal glucose levels to experience a faster decline in kidney function over time, according to new data from a long-term ...
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...
Hosted on MSN
Zermatt, Switzerland – Views of the Matterhorn (4K)
Zermatt, nestled at the base of the legendary Matterhorn, is one of Switzerland’s most iconic destinations. This car-free alpine village combines traditional Swiss charm with endless outdoor adventure ...
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by ...
Credit: Getty Images The number of patients diagnosed with CKD continues to rise each year. Those in the health care field need to work together to minimize the number of patients who go undetected ...
A NEW analysis from the STARSHIP study offers significant insights into the management of cerebral perfusion pressure (CPP) in pediatric traumatic brain injury (TBI). The study compared the current ...
After Thursday's plane crash in the Indian city of Ahmedabad, one of the two flight recorders was recovered from the wreckage. The data is expected to provide information about the cause of the ...
Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results